Claudio Punzo

Dr. Claudio Punzo

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CPClaudio Punzo
Claudio Punzo
KKKarl Kornacker
Karl Kornacker
CCConstance L Cepko
Constance L Cepko

23 March 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AVAditya Venkatesh
Aditya Venkatesh
SMShan Ma
Shan Ma
YLYun Z. Le
Yun Z. Le
MHMichael N. Hall
Michael N. Hall
MRMarkus A. Rüegg
Markus A. Rüegg
CPClaudio Punzo
Claudio Punzo
Retinitis pigmentosa (RP) is an inherited photoreceptor degenerative disorder that results in blindness. The disease is often caused by mutations in genes that are specific to rod photoreceptors; however, blindness results from the secondary loss of cones by a still unknown mechanism. Here, we demonstrated that the mammalian target of rapamycin complex 1 (mTORC1) is required to slow the progression of cone death during disease and that constitutive activation of mTORC1 in cones is sufficient to maintain cone function and promote long-term cone survival. Activation of mTORC1 in cones enhanced glucose uptake, retention, and utilization, leading to increased levels of the key metabolite NADPH. Moreover, cone death was delayed in the absence of the NADPH-sensitive cell death protease caspase 2, supporting the contribution of reduced NADPH in promoting cone death. Constitutive activation of mTORC1 preserved cones in 2 mouse models of RP, suggesting that the secondary loss of cones is caused mainly by metabolic deficits and is independent of a specific rod-associated mutation. Together, the results of this study address a longstanding question in the field and suggest that activating mTORC1 in cones has therapeutic potential to prolong vision in RP.

1 January 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CPClaudio Punzo
Claudio Punzo
WXWenjun XIONG
Wenjun XIONG
CCConstance L. Cepko
Constance L. Cepko
Retinitis pigmentosa is characterized by loss of night vision, followed by complete blindness. Over 40 genetic loci for retinitis pigmentosa have been identified in humans, primarily affecting photoreceptor structure and function. The availability of excellent animal models allows for a mechanistic characterization of the disease. Metabolic dysregulation and oxidative stress have been found to correlate with the loss of vision, particularly in cones, the type of photoreceptors that mediate daylight and color vision. The evidence that these problems actually cause loss of vision and potential therapeutic approaches targeting them are discussed.

27 April 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
BHBrian P. Hafler
Brian P. Hafler
NSNatalia Surzenko
Natalia Surzenko
KBKevin T. Beier
Kevin T. Beier
CPClaudio Punzo
Claudio Punzo
JTJeffrey M. Trimarchi
Jeffrey M. Trimarchi
CCConstance L. Cepko
Constance L. Cepko
Previous lineage analyses have shown that retinal progenitor cells (RPCs) are multipotent throughout development, and expression-profiling studies have shown a great deal of molecular heterogeneity among RPCs. To determine if the molecular heterogeneity predicts that an RPC will produce particular types of progeny, clonal lineage analysis was used to investigate the progeny of a subset of RPCs, those that express the basic helix–loop–helix transcription factor, Olig2 . The embryonic Olig2 + RPCs underwent terminal divisions, producing small clones with primarily two of the five cell types being made by the pool of RPCs at that time. The later, postnatal Olig2 + RPCs also made terminal divisions, which were biased toward production of rod photoreceptors and amacrine cell interneurons. These data indicate that the multipotent progenitor pool is made up of distinctive types of RPCs, which have biases toward producing subsets of retinal neurons in a terminal division, with the types of neurons produced varying over time. This strategy is similar to that of the developing Drosophila melanogaster ventral nerve cord, with the Olig 2 + cells behaving as ganglion mother cells.

2 July 2006 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
WKWinston Patrick Kuo
Winston Patrick Kuo
FLFang Liu
Fang Liu
JTJeff Trimarchi
Jeff Trimarchi
CPClaudio Punzo
Claudio Punzo
MLMichael Lombardi
Michael Lombardi
TJTor-Kristian Jenssen
Tor-Kristian Jenssen

1 May 2018 in Cell Reports
Verified
Journal Article
Open access
LPLolita Petit
Lolita Petit
SMShan Ma
Shan Ma
JCJoris Cipi
Joris Cipi
SCShun-Yun Cheng
Shun-Yun Cheng
MZMarina Zieger
Marina Zieger
CPClaudio Punzo
Claudio Punzo
Aerobic glycolysis accounts for ∼80%-90% of glucose used by adult photoreceptors (PRs); yet, the importance of aerobic glycolysis for PR function or survival remains unclear. Here, we further established the role of aerobic glycolysis in murine rod and cone PRs. We show that loss of hexokinase-2 (HK2), a key aerobic glycolysis enzyme, does not affect PR survival or structure but is required for normal rod function. Rods with HK2 loss increase their mitochondrial number, suggesting an adaptation to the inhibition of aerobic glycolysis. In contrast, cones adapt without increased mitochondrial number but require HK2 to adapt to metabolic stress conditions such as those encountered in retinitis pigmentosa, where the loss of rods causes a nutrient shortage in cones. The data support a model where aerobic glycolysis in PRs is not a necessity but rather a metabolic choice that maximizes PR function and adaptability to nutrient stress conditions.